๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Stereotactic Injection of DTI-015 into Recurrent Malignant Gliomas: Phase I/II Trial

โœ Scribed by Hassenbusch, Samuel J.; Nardone, Emilio M.; Levin, Victor A.; Leeds, Norman; Pietronigro, Dennis

Book ID
122190435
Publisher
Neoplasia Press
Year
2003
Tongue
English
Weight
507 KB
Volume
5
Category
Article
ISSN
1522-8002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of irinotecan plus celeco
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma
โœ David A. Reardon; Jennifer A. Quinn; James Vredenburgh; Jeremy N. Rich; Sridhara ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 219 KB

## Abstract ## BACKGROUND In the current study, the authors report a Phase II trial of irinotecan (CPTโ€11), a topoisomerase I inhibitor active against malignant glioma (MG), with celecoxib, a selective COXโ€2 inhibitor, among MG patients with recurrent disease. ## METHODS Patients with MG at any